Skip to main content

Value-Based Care

Value-Based Care

Financial Toxicity Intervention in Patients with Hematologic Malignancies Effective, Improves Adherence and Quality of Life

Chase Doyle

Leukemia, Value-Based Care

First National Study: Geographic Socioeconomic Disparities Mirror Substantial Gaps in Survival in Children with AML

Chase Doyle

Value-Based Care

Frontline Use of Bendamustine plus Rituximab Cost-Effective for Indolent B-Cell Non-Hodgkin Lymphoma

Value-Based Care

Germline Alterations Analysis Has Actionable Value in Selecting Targetable Treatments for Patients with Advanced Cancer

Chase Doyle

Value-Based Care

High Incidence of Adverse Events Linked to Significant Economic Burden in Patients with Chronic Lymphocytic Leukemia

Chase Doyle

Value-Based Care

Hospital Readmissions for Venous Thromboembolism a Substantial Cost in Patients with Cancer

Chase Doyle

Value-Based Care

Increased Utilization of Biosimilars in Oncology Could Save Payers Millions

Value-Based Care

Induction Therapy plus Autologous Stem-Cell Transplantation Still Cost-Effective for Newly Diagnosed Multiple Myeloma

Value-Based Care

Inpatient Costs for Children and Young Adults with Acute Lymphoblastic Leukemia Higher at Specialized Cancer Centers, but for a Good Reason?

Chase Doyle

Value-Based Care

New Value Model Incorporates Long-Term Adverse Effects of Cancer Drugs

1
2
3
4

Page 2 of 4
Results 11 - 20 of 34